MENU
CYTK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cytokinetics (CYTK) Ownership - Who owns Cytokinetics?

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
564
Web
https://www.cytokinetics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.75B
P/E Ratio
N/A
Total Cash
962.54M
Projected Growth
N/A
Total Debt
1.2B
Revenue
87.21M
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash/Share
7.87
Total Debt/Equity
N/A
Revenue/Share
0.73 USD as % of share price

Fundamentals

CYTK
Capitalization
7.75B
P/E Ratio
N/A
Risk (Beta)
0.80
Dividend Yield
N/A
Total Cash
963M
Total Cash/Share
7.87
Total Debt
1.2B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.73%
Revenue
87.2M
ROE
N/A
Book Value
-521.12M
P/B Ratio
60.61
Cash Flow
N/A
Earnings
-6.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
122K
Current Ratio
6.88
Current Revenue Per Employee
3887.55
Dividends Per Share - Security
N/A
EBITDA
-646.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5025.67
Revenue To Assets
-52.35
Shares Held By Institutions
14.7B
Shares Outstanding - Current
122M
Total Liabilities
1.96B
Total Volume MTD
N/A
Value
-1
Gain YTD
29.188
View a ticker or compare two or three
CYTK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CYTK showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in discovery and development of small molecule drug therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
350 Oyster Point Boulevard
Phone
+1 650 624-3000
Employees
564
Web
https://www.cytokinetics.com